Pharmaniaga Bhd (7081) - Total Liabilities

Latest as of March 2026: RM1.87 Billion MYR ≈ $468.97 Million USD

Based on the latest financial reports, Pharmaniaga Bhd (7081) has total liabilities worth RM1.87 Billion MYR (≈ $468.97 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Pharmaniaga Bhd (7081) liquidity interval to measure how many days the company can operate on defensive assets alone.

Pharmaniaga Bhd - Total Liabilities Trend (2012–2025)

This chart illustrates how Pharmaniaga Bhd's total liabilities have evolved over time, based on quarterly financial data. Check Pharmaniaga Bhd liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Pharmaniaga Bhd Competitors by Total Liabilities

The table below lists competitors of Pharmaniaga Bhd ranked by their total liabilities.

Company Country Total Liabilities
High Liner Foods Incorporated
TO:HLF
Canada CA$583.12 Million
Kung Long Batteries Industrial Co Ltd
TW:1537
Taiwan NT$2.01 Billion
Electrovaya Inc.
TO:ELVA
Canada CA$39.26 Million
Nano Dimension Ltd
F:2N5B
Germany €75.28 Million
PC1 Group JSC
VN:PC1
Vietnam ₫15.68 Trillion
Steppe Gold Ltd
TO:STGO
Canada CA$216.62 Million
Jiangsu Safety Wire Rope
SHG:603028
China CN¥2.17 Billion
ICBC Turkey Bank AS
IS:ICBCT
Turkey TL93.98 Billion

Liability Composition Analysis (2012–2025)

This chart breaks down Pharmaniaga Bhd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Pharmaniaga Bhd's balance sheet.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.92 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 4.02 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.79 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Pharmaniaga Bhd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Pharmaniaga Bhd (2012–2025)

The table below shows the annual total liabilities of Pharmaniaga Bhd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 RM1.79 Billion
≈ $448.83 Million
-16.40%
2024-12-31 RM2.14 Billion
≈ $536.84 Million
-2.32%
2023-12-31 RM2.19 Billion
≈ $549.57 Million
-0.30%
2022-12-31 RM2.20 Billion
≈ $551.24 Million
+22.84%
2021-12-31 RM1.79 Billion
≈ $448.76 Million
+43.84%
2020-12-31 RM1.24 Billion
≈ $311.98 Million
-0.94%
2019-12-31 RM1.25 Billion
≈ $314.95 Million
-10.29%
2018-12-31 RM1.40 Billion
≈ $351.09 Million
+29.52%
2017-12-31 RM1.08 Billion
≈ $271.08 Million
-6.31%
2016-12-31 RM1.15 Billion
≈ $289.35 Million
+23.13%
2015-12-31 RM936.00 Million
≈ $235.00 Million
+35.46%
2014-12-31 RM691.00 Million
≈ $173.49 Million
+13.65%
2013-12-31 RM608.00 Million
≈ $152.65 Million
-17.28%
2012-12-31 RM735.00 Million
≈ $184.53 Million
--

About Pharmaniaga Bhd

KLSE:7081 Malaysia Medical Distribution
Market Cap
$294.68 Million
RM1.17 Billion MYR
Market Cap Rank
#15012 Global
#175 in Malaysia
Share Price
RM0.90
Change (1 day)
-2.72%
52-Week Range
RM0.23 - RM1.38
All Time High
RM1.38
About

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more